Alpha Tau Medical Ltd. (DRTS) Stock Price, Quote & News

AI Score

Unlock

AI Score

Our AI model analyzes fundamental, technical, and statistical indicators to predict the probability of a bullish trend over the next three months.

We regularly update and refine our models to deliver the most reliable forecasts for you.

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

Alpha Tau Medical Ltd. (DRTS)

AI Score

Unlock

AI Score

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

3.98

0.28 (7.57%)

At close: Jan 14, 2025, 3:59 PM

4.00

0.50%

Pre-market Jan 15, 2025, 06:01 AM EST

undefined% (undefined)

Bid	3.87
Market Cap	278.30M
Revenue (ttm)	-
Net Income (ttm)	-
EPS (ttm)	-0.49
PE Ratio (ttm)	-8.12
Forward PE	n/a
Analyst	Buy

Ask	4
Volume	350,600
Avg. Volume (20D)	50,288
Open	3.90
Previous Close	3.70
Day's Range	3.65 - 4.08
52-Week Range	1.75 - 4.08
Beta	undefined

About DRTS

Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, engages in research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer In Israel and the United States. Its Alpha-DaRT technology used in clinical trials for skin, oral, pancreatic, and breast cancers; and preclinical studies for hepatic cell carcinoma, glioblastoma multiforme, lung cancer, and othe...

[Show more]

Industry Biotechnology

Sector Healthcare

IPO Date Mar 8, 2021

Employees 121

Stock Exchange NASDAQ

Ticker Symbol DRTS

Website https://www.alphatau.com

Analyst Forecast

According to 2 analyst ratings, the average rating for DRTS stock is "Buy." The 12-month stock price forecast is $8, which is an increase of 101.01% from the latest price.

Buy 100.00%

Hold 0.00%

Sell 0.00%

Stock Forecasts

News

11 months ago · zacks.com

Is Alpha Tau Medical (DRTS) Stock Outpacing Its Medical Peers This Year?

Here is how Alpha Tau Medical Ltd. (DRTS) and Regeneron (REGN) have performed compared to their sector so far this year.

1 year ago · zacks.com

Best Momentum Stocks to Buy for January 8th

AKYA, DRTS and TRUP made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on January 8, 2024.

1 year ago · zacks.com

New Strong Buy Stocks for January 8th

TIMB, AKYA, DRTS, TRUP and QSG have been added to the Zacks Rank #1 (Strong Buy) List on January 8, 2024.

1 year ago · zacks.com

Down -20.29% in 4 Weeks, Here's Why You Should You Buy the Dip in Alpha Tau Medical Ltd. (DRTS)

Alpha Tau Medical Ltd. (DRTS) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it.

1 year ago · zacks.com

Should You Buy Alpha Tau Medical (DRTS) Ahead of Earnings?

Alpha Tau Medical (DRTS) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

2 years ago · businesswire.com

OurCrowd Launches $200 Million Global Health Equity Fund in collaboration with the WHO Foundation at the Clinton Global Initiative

NEW YORK--(BUSINESS WIRE)--OurCrowd, a leading global venture firm, announced today the launch of a Global Health Equity Fund (GHEF) in collaboration with the WHO Foundation. The news was shared at th...

2 years ago · stockmarket.com

4 Top Biotech Stocks To Watch Today

As the industry continues to make new discoveries, could biotech stocks be in focus?

2 years ago · seekingalpha.com

Alpha Tau: Treating Cancer With Precision Alpha Radiation

Alpha Tau Medical's proprietary Alpha DaRT device safely delivers alpha radiation with localized precision to treat cancers.

2 years ago · benzinga.com

12 Stocks Halted On A Circuit Breaker This Week

A circuit breaker is an automatic, temporary trading halt on certain securities when the underlying stock is experiencing times of high volatility. It is a measure put in place to help restore, and br...